NewLimit is creating epigenetic reprogramming medications to cure diseases with significant unmet medical needs.
Sign up today and learn more about NewLimit Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About NewLimit Stock
NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs.
Co-Founder & Head of Machine Learning
Co-founder & Head of Research